More answers like this
Grok 4.5Oct 13, 2026x-ai/grok-4.5-20260708

Is the US prepared to deal with another pandemic or widespread health crisis?

No, the US is not fully prepared for another pandemic or widespread health crisis, though it has made meaningful improvements in some areas since COVID-19. Assessments from the Government Accountability Office (GAO), bipartisan commissions, public health organizations, and experts consistently highlight progress in stockpiles, surveillance, and coordination structures alongside persistent gaps in funding, leadership implementation, state-level readiness, supply chains, and political/institutional continuity.[1][2]

Improvements Since COVID-19

The US has strengthened certain capabilities:

•Strategic National Stockpile (SNS): Significantly restocked. By early 2025 reporting, it held roughly 70 times more N95 respirators, 34 times more gloves, 50 times more isolation gowns, and 10 times more ventilators than pre-pandemic levels. It has supported responses to mpox (shipping over 1 million vaccine vials and treatments), H5N1 bird flu (PPE and antivirals), and other events. It maintains antibiotics, antivirals, vaccines, PPE, ventilators, and more for rapid deployment.[3][4]
•Surveillance and data: Electronic case reporting expanded dramatically (from under 200 healthcare facilities pre-COVID to over 45,000–48,000 by late 2024), with improved syndromic surveillance and wastewater monitoring. CDC has advanced forecasting and lab partnerships (“warm bases”).[5]
•Structures and investments: Creation of the White House Office of Pandemic Preparedness and Response Policy (OPPR) in 2023 (via PREVENT Pandemics Act) for coordination. Investments in mRNA platforms, medical countermeasures via BARDA/PHEMCE, global health security partnerships, and domestic manufacturing efforts (e.g., PPE forecasts). The Biden administration’s roadmap highlighted massive vaccination/testing/treatment scale-up during COVID and left playbooks for successors.[6][3]
•Other: More states in nurse licensure compacts for surge staffing; accreditation gains in public health/emergency management; some advances in diagnostics and therapeutics pipelines.[7]

These build on lessons from COVID-19’s over 1 million US deaths and earlier warnings (the US ranked highly prepared on paper in 2019 Global Health Security Index but performed poorly).[8]

Persistent and Recurring Gaps

Multiple independent reviews find the nation remains vulnerable:

•GAO findings: HHS leadership and coordination of public health emergencies is a high-risk area. As of mid-2024, hundreds of COVID-related recommendations (over 220 of ~428) remained open. Lessons span planning, collaboration, communications, data sharing, program integrity, and flexibilities. Mpox response (2022) repeated challenges like vaccine/test access and distribution issues. Recent GAO work notes lacks of a coordinated national diagnostic testing strategy/forum and better after-action processes across HHS. Funding and manufacturing risks for countermeasures persist.[1][9][10]
•Bipartisan Commission on Biodefense (2024 National Blueprint): The biological threat is real and growing (natural, accidental, or deliberate). Despite some progress, the nation is “dangerously vulnerable” and “biodefense in crisis.” It calls for immediate action on leadership, intelligence, science/tech, preparedness, detection/surveillance, and response/recovery. Fragmented efforts and on-again/off-again investment fail to match the threat; full implementation of prior recommendations (including an “Apollo Program”-scale effort) could prevent pandemics, but apathy risks worse outcomes than COVID.[2][11]
•State and local readiness (Trust for America’s Health Ready or Not 2025): 21 states + DC in high tier, 16 medium, 13 low based on indicators like funding, lab surge capacity, flu vaccination (~47% in 2023–24, far below 70% goal), paid time off access, hospital safety, water systems, and a new avoidable mortality measure (highlighting disparities). Many states cut public health funding post-COVID emergency dollars; workforce and infrastructure strains continue. Special focus on H5N1 bird flu risks.[7][7]
•Funding and supply chains: PHEMCE multi-year needs far exceed appropriations (e.g., multi-billion shortfalls projected). Domestic manufacturing of items like medical gloves has faced setbacks despite investments. PAHPA reauthorization and sustained public health funding remain critical but incomplete.[12]
•Broader issues: Healthcare workforce shortages/burnout, hospital capacity limits, inequities, misinformation/low trust, political polarization, and coordination frictions (federal-state, interagency). Early H5N1 (in cattle/poultry/workers) responses drew criticism for insufficient urgency in some analyses.[8]

Recent Developments and Risks (Post-2024)

Political transitions have introduced new uncertainties. The OPPR, created to provide permanent White House coordination, was significantly understaffed or sidelined after 2025 (reports of it operating with minimal or no full staff at times, leadership turnover). There have been concerns over cuts or shifts away from certain pandemic R&D, emerging infectious disease programs, and biodefense priorities at agencies like NIAID/NIH, alongside ongoing H5N1 monitoring and other outbreaks (e.g., measles). Experts warn this erodes hard-won capacity and leaves gaps against natural or engineered threats.[13][14]

Global efforts (e.g., WHO pandemic agreement progress, Pandemic Fund) continue with US involvement historically, but domestic readiness is foundational.[15]

Bottom Line and Path Forward

The US is better equipped in tools and stockpiles than in early 2020 and has institutional lessons documented, but systemic weaknesses in sustained funding, full implementation of reforms, seamless multi-level coordination, public trust, and resilient supply chains/healthcare capacity mean it is not adequately prepared for a severe, widespread crisis (especially one more lethal/transmissible than COVID or involving novel agents). Concurrent disasters (climate, cyber) compound risks.[16][17]

Experts and reports urge: stable multi-year funding for public health/PHEP/HPP/SNS/PHEMCE; stronger HHS/White House leadership and after-action learning; national strategies for testing/countermeasures; workforce investments; equity-focused planning; accelerated MCM development/stockpiling; and consistent political prioritization beyond crises. Without these, the pattern of “forget and underinvest” after emergencies risks repeating. Preparedness is achievable with sustained action but currently incomplete.[18]

This assessment draws from nonpartisan GAO audits, bipartisan commissions, TFAH state scorecards, official roadmaps, and expert analyses current through available 2025–2026 reporting. Situations evolve with new threats (e.g., H5N1 mutations), funding, and policy.

Citations (18)

  1. 1gao.govGovernment
    https://www.gao.gov/products/gao-24-107175

    Backs: “Assessments from the Government Accountability Office (GAO), bipartisan commissions, public health organizations, and experts consistently highlight progress in stockpiles, surveillance, and coordination structures alongside persistent gaps in funding, leadership implementation, state-level readiness, supply chains,…”

  2. 2biodefensecommission.orgNonprofits and think tanks
    https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/

    Backs: “Assessments from the Government Accountability Office (GAO), bipartisan commissions, public health organizations, and experts consistently highlight progress in stockpiles, surveillance, and coordination structures alongside persistent gaps in funding, leadership implementation, state-level readiness, supply chains,…”

  3. 3archives.govGovernment
    https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/

    Backs: “It maintains antibiotics, antivirals, vaccines, PPE, ventilators, and more for rapid deployment.”

  4. 4aspr.govGovernment
    https://www.aspr.gov/readiness-response/medical-countermeasures-biodefense/sns/emergency-response/response-history

    Backs: “It maintains antibiotics, antivirals, vaccines, PPE, ventilators, and more for rapid deployment.”

  5. 5cdc.govGovernment
    https://www.cdc.gov/washington/testimony/2024/t20241114.htm

    Backs: “CDC has advanced forecasting and lab partnerships (“warm bases”).”

  6. 6ucsb.eduAcademic
    https://www.presidency.ucsb.edu/documents/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response

    Backs: “The Biden administration’s roadmap highlighted massive vaccination/testing/treatment scale-up during COVID and left playbooks for successors.”

  7. 7tfah.orgNonprofits and think tanks
    https://www.tfah.org/article/new-report-measures-states-preparedness-for-public-health-emergencies-including-infectious-disease-outbreaks-and-extreme-weather-events/

    Backs: “More states in nurse licensure compacts for surge staffing; accreditation gains in public health/emergency management; some advances in diagnostics and therapeutics pipelines.”

  8. 8nejm.orgAcademic
    https://www.nejm.org/doi/full/10.1056/NEJMp2406427

    Backs: “These build on lessons from COVID-19’s over 1 million US deaths and earlier warnings (the US ranked highly prepared on paper in 2019 Global Health Security Index but performed poorly).”

  9. 9gao.govGovernment
    https://www.gao.gov/products/gao-24-106276

    Backs: “Funding and manufacturing risks for countermeasures persist.”

  10. 10gao.govGovernment
    https://www.gao.gov/products/gao-25-106980

    Backs: “Funding and manufacturing risks for countermeasures persist.”

  11. 11biodefensecommission.orgNonprofits and think tanks
    https://biodefensecommission.org/wp-content/uploads/2024/05/National-Blueprint-for-Biodefense-2024_final_.pdf

    Backs: “Fragmented efforts and on-again/off-again investment fail to match the threat; full implementation of prior recommendations (including an “Apollo Program”-scale effort) could prevent pandemics, but apathy risks worse outcomes than COVID.”

  12. 12center-forward.orgNonprofits and think tanks
    https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/

    Backs: “PAHPA reauthorization and sustained public health funding remain critical but incomplete.”

  13. 13cnn.comNews and mediaquality 0.66
    https://www.cnn.com/2025/03/17/health/pandemic-preparedness-office-trump-bird-flu

    Backs: “Experts warn this erodes hard-won capacity and leaves gaps against natural or engineered threats.”

  14. 14science.orgAcademic
    https://www.science.org/content/article/trump-administration-dismantling-efforts-fight-next-pandemic

    Backs: “Experts warn this erodes hard-won capacity and leaves gaps against natural or engineered threats.”

  15. 15archives.govGovernment
    https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2024/12/11/fact-sheet-biden-harris-administration-releases-global-health-security-annual-report-demonstrating-the-impact-of-united-states-leadership-and-investments/

    Backs: “Global efforts (e.g., WHO pandemic agreement progress, Pandemic Fund) continue with US involvement historically, but domestic readiness is foundational.”

  16. 16stimson.orgNonprofits and think tanks
    https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/

    Backs: “The US is better equipped in tools and stockpiles than in early 2020 and has institutional lessons documented, but systemic weaknesses in sustained funding, full implementation of reforms, seamless multi-level coordination, public trust, and resilient supply chains/healthcare capacity mean it is not adequately…”

  17. 17govinfo.govGovernment
    https://www.govinfo.gov/content/pkg/CMR-HS5_100-00193235/pdf/CMR-HS5_100-00193235.pdf

    Backs: “The US is better equipped in tools and stockpiles than in early 2020 and has institutional lessons documented, but systemic weaknesses in sustained funding, full implementation of reforms, seamless multi-level coordination, public trust, and resilient supply chains/healthcare capacity mean it is not adequately…”

  18. 18bmj.comAcademic
    https://www.bmj.com/content/384/bmj.q332

    Backs: “Preparedness is achievable with sustained action but currently incomplete.”